sparfloxacin has been researched along with Koch's Disease in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (66.67) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balasubramanian, V; Bharath, S; Gaonkar, S; Jayaram, R; Jayashree, R; Kaur, P; Mahesh, BN; Nandi, V; Shandil, RK; Suresh, BL | 1 |
| Cheng, XW; Fan, YL; Feng, LS; Wu, JB; Zhang, FZ | 1 |
| De Souza, MV; Junior, IN; Lourenço, MC | 1 |
| Grosset, J; JI, B; Lounis, N; Truffot-Pernot, C | 1 |
| Gillespie, SH; Kennedy, N | 1 |
| Singhal, P | 1 |
| Bhowmik, D; Gupta, S | 1 |
| Kaur, D; Khuller, GK | 1 |
| Shankar, PS | 1 |
| Kamat, SR | 1 |
| Cascina, A; Fietta, A; Morosini, M | 1 |
| Cohen, Y; Grosset, J; Perronne, C; Pocidalo, JJ; Truffot-Pernot, C; Vildé, JL | 1 |
| Grosset, JH | 1 |
| Saito, H; Sato, K; Tomioka, H | 1 |
| Grosset, J; Ji, B; Truffot-Pernot, C | 1 |
2 review(s) available for sparfloxacin and Koch's Disease
| Article | Year |
|---|---|
Fluoroquinolone derivatives and their anti-tubercular activities.
Topics: Animals; Antitubercular Agents; Dose-Response Relationship, Drug; Fluoroquinolones; Humans; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis | 2018 |
Treatment of tuberculosis in HIV infection.
Topics: AIDS-Related Opportunistic Infections; Animals; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Fluoroquinolones; Humans; Mice; Quinolones; Tuberculosis | 1992 |
13 other study(ies) available for sparfloxacin and Koch's Disease
| Article | Year |
|---|---|
Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Aza Compounds; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fluoroquinolones; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Predictive Value of Tests; Quinolines; Time Factors; Tuberculosis | 2007 |
In vitro activity of ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and gatifloxacin against multidrug-resistant Mycobacterium tuberculosis in Rio de Janeiro Brazil.
Topics: AIDS-Related Opportunistic Infections; Brazil; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Tuberculosis | 2007 |
In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis.
Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Isomerism; Isoniazid; Levofloxacin; Lung; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Quinolones; Spleen; Splenomegaly; Survival Rate; Tuberculosis | 1995 |
Treatment of tuberculosis in HIV infection.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antitubercular Agents; Fluoroquinolones; Humans; Quinolones; Tuberculosis | 1993 |
Sparfloxacin in tuberculosis.
Topics: Anti-Infective Agents; Antitubercular Agents; Fluoroquinolones; Humans; Tuberculosis | 1999 |
Sparfloxacin in mycobacterial infections.
Topics: Anti-Infective Agents; Antitubercular Agents; Fluoroquinolones; Humans; Tuberculosis | 1999 |
In vitro, ex-vivo and in vivo activities of ethambutol and sparfloxacin alone and in combination against mycobacteria.
Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Colony Count, Microbial; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium Infections, Nontuberculous; Mycobacterium smegmatis; Mycobacterium tuberculosis; Tuberculosis | 2001 |
Sparfloxacin in tuberculosis.
Topics: Anti-Infective Agents; Antitubercular Agents; Fluoroquinolones; Humans; Tuberculosis | 1998 |
Early experience with sparfloxacin in tuberculosis.
Topics: Adult; Anti-Infective Agents; Antitubercular Agents; Female; Fluoroquinolones; Humans; Male; Middle Aged; Retrospective Studies; Tuberculosis | 1998 |
Effects of continuous or pulsed exposure to rifabutin and sparfloxacin on the intracellular growth of Staphylococcus aureus and Mycobacterium tuberculosis.
Topics: Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Cell Culture Techniques; Fluoroquinolones; Humans; Kinetics; Monocytes; Mycobacterium tuberculosis; Rifabutin; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Tuberculosis | 2001 |
Sparfloxacin, ethambutol, and cortisol receptor inhibitor RU-40 555 treatment for disseminated Mycobacterium avium complex infection of normal C57BL/6 mice.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Feasibility Studies; Female; Fluoroquinolones; Glucocorticoids; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mifepristone; Mycobacterium avium; Quinolones; Receptors, Glucocorticoid; Spleen; Time Factors; Tuberculosis | 1992 |
[Antimycobacterial activities of a new quinolone, sparfloxacin].
Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Drug Resistance, Microbial; Fluoroquinolones; Mice; Mycobacterium; Mycobacterium avium; Mycobacterium tuberculosis; Quinolones; Tuberculosis | 1991 |
In vitro and in vivo activities of sparfloxacin (AT-4140) against Mycobacterium tuberculosis.
Topics: Animals; Anti-Infective Agents; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Quinolones; Tuberculosis | 1991 |